دورية أكاديمية

Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients

التفاصيل البيبلوغرافية
العنوان: Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients
المؤلفون: Tozuka, TakehiroAff1, Aff2, Yanagitani, Noriko, Yoshida, Hiroshi, Manabe, Ryo, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Sakamoto, Hiroaki, Amino, Yoshiaki, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Seike, Masahiro, Gemma, Akihiko, Nishio, MakotoAff1, IDs10637023013583_cor14
المصدر: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(3):411-420
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:01676997
15730646
DOI:10.1007/s10637-023-01358-3